• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21世纪的心力衰竭:它是冠状动脉疾病问题还是高血压问题?

Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?

作者信息

Velagaleti Raghava S, Vasan Ramachandran S

机构信息

Framingham Heart Study, Framingham, MA 01702-5803, USA.

出版信息

Cardiol Clin. 2007 Nov;25(4):487-95; v. doi: 10.1016/j.ccl.2007.08.010.

DOI:10.1016/j.ccl.2007.08.010
PMID:18063154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2350191/
Abstract

Hypertension and coronary disease are major risk factors for the incidence and progression of heart failure. These two risk factors frequently coexist, and have additive and synergistic effects that promote both left ventricular remodeling and heart failure in the general population. The relative contributions of these two risk factors to heart failure burden in the community may vary based on age, gender, and race. In general, attribution of heart failure in the community to solely one of these two risk factors is inappropriate. Prevention of both hypertension and coronary disease is important for preventing heart failure in the twenty-first century.

摘要

高血压和冠状动脉疾病是心力衰竭发生和进展的主要危险因素。这两种危险因素经常并存,并具有累加和协同效应,可促进普通人群的左心室重塑和心力衰竭。这两种危险因素对社区心力衰竭负担的相对贡献可能因年龄、性别和种族而异。一般来说,将社区中的心力衰竭单纯归因于这两种危险因素中的某一种是不合适的。在21世纪,预防高血压和冠状动脉疾病对于预防心力衰竭都很重要。

相似文献

1
Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem?21世纪的心力衰竭:它是冠状动脉疾病问题还是高血压问题?
Cardiol Clin. 2007 Nov;25(4):487-95; v. doi: 10.1016/j.ccl.2007.08.010.
2
Risk factors for heart failure: a population-based case-control study.心力衰竭的危险因素:一项基于人群的病例对照研究。
Am J Med. 2009 Nov;122(11):1023-8. doi: 10.1016/j.amjmed.2009.04.022.
3
Predictors of heart failure among women with coronary disease.冠心病女性心力衰竭的预测因素。
Circulation. 2004 Sep 14;110(11):1424-30. doi: 10.1161/01.CIR.0000141726.01302.83. Epub 2004 Sep 7.
4
Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?心血管危险因素的最佳医学治疗:我们能否预防心力衰竭的发生?
Expert Rev Cardiovasc Ther. 2009 Feb;7(2):147-57. doi: 10.1586/14779072.7.2.147.
5
Coronary artery disease and prevention of heart failure.冠状动脉疾病与心力衰竭的预防
Med Clin North Am. 2004 Sep;88(5):1209-35. doi: 10.1016/j.mcna.2004.03.002.
6
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.老年人未来致命性与非致命性冠心病事件的特征及基线临床预测因素:心血管健康研究
Circulation. 2006 May 9;113(18):2177-85. doi: 10.1161/CIRCULATIONAHA.105.610352. Epub 2006 May 1.
7
Prevention of Heart Failure in Hypertension-the Role of Coronary Heart Disease Events Treated With Versus Without Revascularization: The ALLHAT Study.高血压中心力衰竭的预防——经与未经血运重建治疗的冠心病事件的作用:ALLHAT 研究。
Am J Cardiol. 2024 Nov 15;231:1-10. doi: 10.1016/j.amjcard.2024.08.033. Epub 2024 Sep 5.
8
Heart failure in North America.北美地区的心力衰竭
Curr Cardiol Rev. 2013 May;9(2):128-46. doi: 10.2174/1573403x11309020006.
9
Management of heart failure and coronary artery disease in patients with chronic kidney disease.
Semin Dial. 2003 Mar-Apr;16(2):165-72. doi: 10.1046/j.1525-139x.2003.16033.x.
10
Incidence and epidemiology of heart failure.心力衰竭的发病率与流行病学
Heart Fail Rev. 2000 Jun;5(2):167-73. doi: 10.1023/A:1009884820941.

引用本文的文献

1
Association Between Revascularization and 30-Day Survival of Ischemic Cardiomyopathy Patients in Dr. Hasan Sadikin General Hospital.哈桑·萨迪金综合医院缺血性心肌病患者血运重建与30天生存率的关联
Vasc Health Risk Manag. 2025 Sep 3;21:719-728. doi: 10.2147/VHRM.S524863. eCollection 2025.
2
Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography-Based Device Compared to Invasive Pulmonary Artery Catheter.使用基于无创光电容积脉搏波描记术的设备与有创肺动脉导管相比评估心脏血流测量。
JACC Adv. 2025 Aug 21;4(9):102093. doi: 10.1016/j.jacadv.2025.102093.
3
Association between multivessel disease and outcomes in acute lower limb ischemia: A cohort study.多支血管病变与急性下肢缺血预后的关联:一项队列研究。
Sci Prog. 2025 Jul-Sep;108(3):368504251355146. doi: 10.1177/00368504251355146. Epub 2025 Aug 18.
4
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Patients under Percutaneous Coronary Intervention with High Pulse Pressure.高脉压经皮冠状动脉介入治疗患者心肺运动试验参数的预测价值
Rev Cardiovasc Med. 2025 Feb 18;26(2):25847. doi: 10.31083/RCM25847. eCollection 2025 Feb.
5
Safety of Vericiguat in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis.维立西呱在冠状动脉疾病患者中的安全性:一项系统评价和荟萃分析。
Am J Cardiovasc Drugs. 2025 Mar;25(2):241-248. doi: 10.1007/s40256-024-00701-0. Epub 2024 Dec 6.
6
Knowledge, attitude, and practice of Palestinian critical care nurses about hemodynamic instability in patients with cardiovascular diseases.巴勒斯坦重症护理护士对心血管疾病患者血流动力学不稳定的知识、态度和实践。
BMC Nurs. 2024 Dec 2;23(1):871. doi: 10.1186/s12912-024-02549-w.
7
Tanshinone IIA Exerts Cardioprotective Effects Through Improving Gut-Brain Axis Post-Myocardial Infarction.丹参酮 IIA 通过改善心肌梗死后的肠-脑轴发挥心脏保护作用。
Cardiovasc Toxicol. 2024 Dec;24(12):1317-1334. doi: 10.1007/s12012-024-09928-4. Epub 2024 Oct 8.
8
Effect of the Mediterranean diet on incidence of heart failure in European countries: a systematic review and meta-analysis of cohort studies.地中海饮食对欧洲国家心力衰竭发病率的影响:队列研究的系统评价和荟萃分析
Eur J Clin Nutr. 2025 Mar;79(3):195-199. doi: 10.1038/s41430-024-01519-4. Epub 2024 Oct 1.
9
The Cardioprotective Potential of Herbal Formulas in Myocardial Infarction-Induced Heart Failure through Inhibition of JAK/STAT3 Signaling and Improvement of Cardiac Function.中药复方通过抑制JAK/STAT3信号通路和改善心功能对心肌梗死所致心力衰竭的心脏保护作用
Pharmaceuticals (Basel). 2024 Aug 27;17(9):1132. doi: 10.3390/ph17091132.
10
Exploring Predictive Factors for Heart Failure Progression in Hypertensive Patients Based on Medical Diagnosis Data from the MIMIC-IV Database.基于MIMIC-IV数据库的医学诊断数据探索高血压患者心力衰竭进展的预测因素。
Bioengineering (Basel). 2024 May 23;11(6):531. doi: 10.3390/bioengineering11060531.

本文引用的文献

1
Serial assessment of left ventricular function in various patient groups with Tl-201 gated myocardial perfusion SPECT.采用铊-201 门控心肌灌注单光子发射计算机断层扫描对不同患者群体的左心室功能进行系列评估。
Radiat Med. 2007 Feb;25(2):65-72. doi: 10.1007/s11604-006-0105-3. Epub 2007 Feb 27.
2
Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.社区样本中醛固酮与肾素比值的临床和遗传相关性及其与血压的关系
Hypertension. 2007 Apr;49(4):846-56. doi: 10.1161/01.HYP.0000258554.87444.91. Epub 2007 Feb 12.
3
Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease.典型胸痛与冠状动脉造影正常:心脏危险因素分析与正电子发射断层扫描用于检测微血管疾病的比较
J Nucl Med. 2007 Feb;48(2):175-81.
4
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2007年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2007 Feb 6;115(5):e69-171. doi: 10.1161/CIRCULATIONAHA.106.179918. Epub 2006 Dec 28.
5
Multiple biomarkers for the prediction of first major cardiovascular events and death.用于预测首次重大心血管事件和死亡的多种生物标志物。
N Engl J Med. 2006 Dec 21;355(25):2631-9. doi: 10.1056/NEJMoa055373.
6
Diurnal blood pressure pattern and risk of congestive heart failure.日间血压模式与充血性心力衰竭风险
JAMA. 2006 Jun 28;295(24):2859-66. doi: 10.1001/jama.295.24.2859.
7
Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
Hypertension. 2006 Jun;47(6):1125-30. doi: 10.1161/01.HYP.0000221223.23028.f1. Epub 2006 Apr 17.
8
Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.心肌病的当代定义和分类:美国心脏协会临床心脏病学理事会、心力衰竭与移植委员会的科学声明;医疗质量与结果研究及功能基因组学与转化生物学跨学科工作组;以及流行病学与预防理事会。
Circulation. 2006 Apr 11;113(14):1807-16. doi: 10.1161/CIRCULATIONAHA.106.174287. Epub 2006 Mar 27.
9
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.执行摘要:HFSA 2006 年《心力衰竭综合实践指南》。
J Card Fail. 2006 Feb;12(1):10-38. doi: 10.1016/j.cardfail.2005.12.001.
10
Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.来自不同生物学途径的多种生物标志物与肱动脉内皮功能的横断面关系。
Circulation. 2006 Feb 21;113(7):938-45. doi: 10.1161/CIRCULATIONAHA.105.580233. Epub 2006 Feb 13.